Primary multicentric angiosarcoma of bone: true entity or metastases from an unknown primary? Value of comparative genomic hybridization on paraffin embedded tissues
Juliette Thariat,
Isabelle Peyrottes,
Frédéric Chibon,
Maxime Benchetrit,
Esma Saada,
Lauris Gastaud,
Olivier Dassonville,
Antoine Iannessi,
Antione Thyss
Affiliations
Juliette Thariat
Department of Radiation Oncology, Center Antoine-Lacassagne, Nice
Isabelle Peyrottes
Department of Pathology, Center Antoine-Lacassagne, Nice
Frédéric Chibon
Department of Pathology, Institut Bergonié, Bordeaux
Maxime Benchetrit
Department of Pathology, Centre Hospitalier Universitaire, Nice
Esma Saada
Department of Medical Oncology, Center Antoine-Lacassagne, Nice
Lauris Gastaud
Department of Medical Oncology, Center Antoine-Lacassagne, Nice
Olivier Dassonville
Department of Head and Neck Surgery, Center Antoine-Lacassagne, Nice
Antoine Iannessi
Department of Radiology, Center Antoine-Lacassagne, Nice
Antione Thyss
Department of Medical Oncology, Center Antoine-Lacassagne, Nice
Multicentric primary angiosarcoma of bone has been described as a distinct entity from bone metastases from angiosarcoma. Bone angiosarcoma accounts for less than 1% of sarcomas. It has dismal prognosis overall, but the multicentric expression does not confer worse prognosis. We describe the case of an old male with bone angiosarcoma of the extremities with multicentric presentation. He soon after had soft tissue angiosarcoma of the head and neck. Histology and immunohistochemistry were consistent with the diagnosis of high-grade angiosarcoma. Comparative genomic hybridization on paraffin-embedded samples of the bone and head and neck samples suggested additional abnormalities in the bone fragment, thus suggesting than bone lesions were indeed metastatic from his head and neck angiosarcoma; although these preliminary analyses warrant confirmation in other similar rare cases. The patient died after 3 years of relapsed acute leukemia with progressive angiosarcoma.